Medical imaging company Guerbet LLC USA Tuesday announced the launch of a group purchasing agreement with Premier Inc for the former's microcatheters SeQure and DraKon.

According to Guerbet, its SeQure and DraKon are two novel microcatheters intended for the infusion of therapeutic agents, contrast media and embolics into peripheral vessels.

At their discretion, the Premier members will access Guerbet LLC USA's microcatheters, which offer optimal intra-arterial navigation to interventionalists and provide novel solutions to further enhance and secure embolisation procedures.

The company added that the SeQure device uses flow dynamics to create a fluid barrier designed to deliver treatment to a target vessel to reduce the risk of non-target embolization. The device features side slits designed to allow the outflow of contrast media to create a fluid barrier around the microcatheter to reduce microspheres reflux and to aid in delivery to the target vessel. The DraKon peripheral device is a standard end hole microcatheter with optimised pushability, flexibility and torqueability.